Skip to main content
HR 4384 112th Congress House Health Consumer affairs Drug safety, medical device, and laboratory regulation Health information and medical records Prescription drugs

Patient Safety and Drug Labeling Improvement Act

Introduced: April 18, 2012 Introduced by: Van Hollen, Chris Democratic · Maryland See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 20, 2012
Referred to the Subcommittee on Health.
Apr 18, 2012
Referred to the House Committee on Energy and Commerce.
Apr 18, 2012
Introduced in House
 Plain-English summary Congressional Research Service

Patient Safety and Drug Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application.

Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.

What's happening now April 20, 2012

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2